EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tapered chiral nanoparticles as broad-spectrum thermally stable antivirals for SARS-CoV-2 variants

Rui Gao iD, Xinxin Xu, Prashant Kumar, Ye Liu, Hongyu Zhang, Xiao Guo, Maozhong Sun, Felippe Mariano Colombari, André F de Moura iD, Changlong Hao, Jessica Ma, Emine Sumeyra Turali Emre iD und 5 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2310469121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Rui Gao und 16 weiteren Autor:innen. Beteiligte Einrichtung: International Joint Research Laboratory for Biointerface and Biodetection, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu …. Hauptthemen laut MEDLINE: COVID-19, Coronavirus OC43, Human. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Science Foundation (NSF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incessant mutations of viruses, variable immune responses, and likely emergence of new viral threats necessitate multiple approaches to novel antiviral therapeutics. Furthermore, the new antiviral agents should have broad-spectrum activity and be environmentally stable. Here, we show that biocompatible tapered CuS nanoparticles (NPs) efficiently agglutinate coronaviruses with binding affinity dependent on the chirality of surface ligands and particle shape. L- penicillamine-stabilized NPs with left-handed curved apexes display half-maximal inhibitory concentrations (IC 50 ) as low as 0.66 pM (1.4 ng/mL) and 0.57 pM (1.2 ng/mL) for pseudo-type SARS-CoV-2 viruses and wild-type Wuhan-1 SARS-CoV-2 viruses, respectively, which are about 1,100 times lower than those for antibodies (0.73 nM). Benefiting from strong NPs–protein interactions, the same particles are also effective against other strains of coronaviruses, such as HCoV-HKU1, HCoV-OC43, HCoV-NL63, and SARS-CoV-2 Omicron variants with IC 50 values below 10 pM (21.8 ng/mL). Considering rapid response to outbreaks, exposure to elevated temperatures causes no change in the antiviral activity of NPs while antibodies are completely deactivated. Testing in mice indicates that the chirality-optimized NPs can serve as thermally stable analogs of antiviral biologics complementing the current spectrum of treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Coronavirus OC43, HumanHumansAnimalsMiceSARS-CoV-2AntibodiesAntiviral Agents

Stichwörter der Autor:innen

biomimeticcapsidschiral nanoparticlesself-assemblysupraparticles

Substanzen

AntibodiesAntiviral Agents

Autor:innen und Institutionen

  • International Joint Research Laboratory for Biointerface and Biodetection, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, People's Republic of China.
  • State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, People's Republic of China.
  • Department of Materials Science and Engineering, University of Michigan, Ann Arbor, MI 48109.
  • Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109.
  • Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109.
  • Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan 650000, People's Republic of China.

ORCID-Profile: Rui Gao, André F de Moura, Emine Sumeyra Turali Emre, Minjeong Cha, Hua Kuang, Nicholas A Kotov, Chuanlai Xu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • National Science Foundation (NSF)

Zitieren

APA

Gao, R., Xu, X., Kumar, P., Liu, Y., Zhang, H., Guo, X., Sun, M., Colombari, F. M., de Moura, A. F., Hao, C., Ma, J., Turali Emre, E. S., Cha, M., Xu, L., Kuang, H., Kotov, N. A., & Xu, C. (2024). Tapered chiral nanoparticles as broad-spectrum thermally stable antivirals for SARS-CoV-2 variants. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2310469121

Vancouver

Gao R, Xu X, Kumar P, Liu Y, Zhang H, Guo X, et al. Tapered chiral nanoparticles as broad-spectrum thermally stable antivirals for SARS-CoV-2 variants. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2310469121

BibTeX
@article{Gao2024,
  author = {Gao, Rui and Xu, Xinxin and Kumar, Prashant and Liu, Ye and Zhang, Hongyu and Guo, Xiao and Sun, Maozhong and Colombari, Felippe Mariano and de Moura, André F and Hao, Changlong and Ma, Jessica and Turali Emre, Emine Sumeyra and Cha, Minjeong and Xu, Liguang and Kuang, Hua and Kotov, Nicholas A and Xu, Chuanlai},
  title = {Tapered chiral nanoparticles as broad-spectrum thermally stable antivirals for SARS-CoV-2 variants},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2310469121}
}
Kostenlos starten →